Latest News - Page 3 of 5 - Evercyte - Forever is just enough

hTERT immortalized ASC for large-scale EV production

hTERT immortalized ASC for large-scale EV production

Recent publication showcasing our ASC/TERT1 cells as EV production system May 23rd, 2024, Vienna, Austria Our telomerized human adipose derived MSC (ASC/TERT1, also

By admin|2026-02-07T10:24:58+00:00May 23rd, 2024|Extracellular vesicles, mesenchymal stromal cells, recent highlights EV, telomerized cells|

Evercyte proudly introduces the EVscale™ platform

Evercyte proudly introduces the EVscale™ platform April 29th, 2024, Vienna, Austria The collaborative effort of Evercyte, Phoenestra, and TAmiRNA has yielded the EVscale™ platform,

By admin|2026-02-07T10:29:56+00:00April 29th, 2024|EVscale, Extracellular vesicles, recent highlights EV|

Newly published study featuring our PODO/TERT256 cell line

Recent publication showcasing our PODO/TERT256 telomerized cell line February 16th, 2024, Vienna, Austria Our telomerized human podocyte cells (PODO/TERT256) were employed in an

By admin|2026-02-07T10:29:35+00:00February 16th, 2024|PODO/TERT256, telomerized cells|

Evercyte contributing to reduce animal testing at key events

Evercyte contributing to reduce animal testing at key events December 7th, 2023, Vienna, Austria We participated as an invited attendee at

By admin|2026-02-07T10:29:13+00:00December 7th, 2023|3Rs, cell line development, conferences, GCCP|

Evercyte Showcases Expertise in Japan’s Pharma Landscape

Evercyte Showcases Expertise in Japan’s Pharma Landscape November 22nd, 2023, Vienna, Austria We recently visited Summit Pharmaceuticals International to present our

By admin|2026-02-07T10:28:46+00:00November 22nd, 2023|cell line development, collaboration, EV cell factories, Extracellular Vesicles, mesenchymal stromal cells|

Participation to the first MOVE symposium

We participated to the first MOVE symposium in Malaga, Spain October 27th, 2023, Vienna, Austria We participated to the first MOVE

By admin|2026-02-07T10:28:27+00:00October 27th, 2023|Extracellular vesicles and ageing, mesenchymal stromal cells|

Participation to the Small New World 2.0 meeting

We participated to the Small New World 2.0 meeting in Graz, Austria September 12th, 2023, Vienna, Austria We participated to the

By admin|2026-02-07T10:28:04+00:00September 19th, 2023|Extracellular vesicles and ageing, mesenchymal stromal cells|

RPTEC/TERT1 relevant kidney-on-a-chip model

Collaboration with Nortis to establish human kidney-on-a-chip model August 4th, 2023. Vienna, Austria Our telomerized Human Renal Proximal Tubular Epithelial cells (RPTEC/TERT1) were used in collaboration with

By admin|2026-02-07T10:27:45+00:00August 4th, 2023|3Rs, collaboration, organ-on-a-chip, RPTEC/TERT1|

We are hiring!

PhD position available ‘Unravel the regenerative potential of EVs in ageing-associated disorders’ August 8th, 2022, Vienna, Austria We are looking for

By Evercyte|2026-02-07T10:27:09+00:00August 8th, 2022|Extracellular vesicles and ageing|

Placenta-derived mesenchymal stem cells

Placenta-derived mesenchymal stem cells

New mesenchymal stromal cell lines from placental tissue for production of exosomes are now available! December 1st, 2021, Vienna, Austria Mesenchymal

By Evercyte|2022-08-08T08:51:10+00:00December 1st, 2021|Mesenchymal stem cells, team member|

Title